Generated by AI
CVRx, Inc. is a commercial-stage medical device company focused on neuromodulation solutions for cardiovascular disease. Its flagship product, Barostim, is an implantable therapy system that delivers electrical pulses to carotid baroreceptors to help regulate autonomic nervous system activity and support cardiovascular function. The company’s current offerings center on Baroreflex Activation Therapy, a minimally invasive treatment approach used for patients with heart failure and other cardiovascular conditions. CVRx develops, manufactures, and commercializes its products in the United States, Germany, and selected international markets through direct sales and distribution channels. Headquartered in Minneapolis, Minnesota, CVRx plays a specialized role in the medical technology market by providing device-based therapies that address complex cardiac care needs.
Website9201 West Broadway Avenue
Minneapolis, MN, 55445
United States
The latest articles about CVRX.
Motley Fool Press Release.
Summary of Oct 14's posts. Generated by AI.
Summary of Apr 8's posts. Generated by AI.
Summary of Jul 26's posts. Generated by AI.
Summary of Sep 30's posts. Generated by AI.
Investors talking about CVRX also mention these. Each card shows that asset’s own numbers for the past 24 hours.
Valuation and earnings.